Laboratoire francais, NanoCarrier deal

NanoCarrier and LFB mutually agreed to temporarily discontinue an October 2010 deal to develop a long-lasting form of recombinant human coagulation Factor VIIa (rhFVIIa) to treat hemophilia. The produ...